Rhode Island SB 581: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES (Establishes audit requirements for pharmacy benefit managers and also establishes annual reporting requirements for health insurers.)
Status: 07/16/2019 Signed by Governor (as of 2019-07-16)
State: Rhode Island · Session: 2019 · Bill: SB 581
Subjects: Business & Professions
Sponsors: Lynch Prata, McCaffrey, McKenney
Bill Text
2019 -- S 0581 SUBSTITUTE A ======== LC002040/SUB A ======== S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 2019 ____________ A N A C T RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES Introduced By: Senators Lynch Prata, McCaffrey, and McKenney Date Introduced: March 14, 2019 Referred To: Senate Health & Human Services It is enacted by the General Assembly as follows: SECTION 1. Chapter 5-19.1 of the General Laws entitled "Pharmacies" is hereby 1 amended by adding thereto the following section: 2 5-19.1-34. Audits . 3 (a) When an on-site audit of the records of a pharmacy is conducted by a carrier or their 4 intermediary, the audit must be conducted in accordance with the following criteria: 5 (1) A finding of overpayment or underpayment must be based on the actual overpayment 6 or underpayment, and not a projection based on the number of patients served having a similar 7 diagnosis, or on the number of similar orders or refills for similar drugs, unless the projected 8 overpayment or denial is a part of a settlement agreed to by the pharmacy or pharmacist; 9 (2) The auditor may not use extrapolation in calculating recoupments or penalties unless 10 required by state or federal laws or regulations; 11 (3) Any audit that involves clinical judgment must be conducted by, or in consultation 12 with, a pharmacist; and 13 (4) Each entity conducting an audit shall establish an appeal process under which a 14 pharmacy may appeal an unfavorable preliminary audit report to the entity. 15 (b) This section does not apply to any audit, review, or investigation that is initiated 16 based on or involving suspected or alleged fraud, willful misrepresentation, or abuse. 17 (c) Prior to an audit, the entity conducting an audit shall give the pharmacy fourteen (14) 18 days advance written notice of the audit and the range of prescription numbers involved in the 19 LC002040/SUB A - Page 2 of 4 audit. The carrier or their intermediary may mask the last two digits of such numbers. 1 Additionally, the number of prescriptions shall not exceed one hundred fifty (150) prescription 2 claims and their applicable refills. The time allotted must be adequate to collect all samples. The 3 examination of signature logs shall not exceed twenty-five (25) signature logs in number. 4 (d) A pharmacy has the right to execute the dispute resolution contained in their contract. 5 (e)(1) A preliminary audit report must be delivered to the pharmacy or its corporate office 6 within sixty (60) days after the conclusion of the audit. A pharmacy must be allowed at least 7 thirty (30) days following receipt of the preliminary audit to provide documentation to address 8 any discrepancy found in the audit. A final audit report must be delivered to the pharmacy or its 9 corporate office within ninety (90) days after receipt of the preliminary audit report or final 10 appeal, whichever is later. A charge-back recoupment or other penalty may not be assessed until 11 the appeal process provided by the pharmacy benefits manager has been exhausted and the final 12 report issued. If the identified discrepancy for a single audit exceeds twenty-five thousand dollars 13 ($25,000), future payments in excess of that amount may be withheld pending the adjudication of 14 an appeal. Auditors shall only have access to previous audit reports on a particular pharmacy 15 conducted for the same entity. 16 (2) Auditors may initiate a desk audit prior to an on-site audit unless otherwise specified 17 in the law. 18 (3) Contracted auditors cannot be paid based on the findings within an audit. 19 (4) Scanned images of all prescriptions including all scheduled controlled substances are 20 allowed to be used by the pharmacist for an audit. Verbally received prescriptions must be 21 accepted upon validation by the auditing entity and applicable for the initial desk or on-site audit. 22 (5) The period covered by an audit may not exceed two (2) years. 23 (6) Within five (5) business days of receiving the audit notification, pharmacies are 24 allowed, at a minimum, one opportunity to reschedule with the auditor if the scheduled audit 25 presents a scheduling conflict for the pharmacist. 26 (f) Any clerical error, typographical error, scrivener's error, or computer error regarding a 27 document or record required under the Medicaid program does not constitute a willful violation 28 and is not subject to criminal penalties without proof of i
View Rhode Island SB 581 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.